The new Dogma meets Thomas Kuhn’s definition of a paradigm shift. The DNA/RNA Dogma is sufficiently unprecedented to attract ...
The global synthetic biology market growth forecasted to transform from USD 12.33 billion in 2024 to USD 31.52 billion in 2029, driven by a CAGR of 20.6%. Rising demand for bio-based products, growing ...
Scientists have achieved a significant milestone generating a large collection of exome data, which include genes that code for proteins -- key to understanding health and disease.
The scientists created an algorithm that reconstructs the epigenetic landscape of ancient brains—chemical modifications to ...
Our records of the human genome may still be missing tens of thousands of 'dark' genes. These hard-to-detect sequences of ...
Synaffix B.V., a Lonza company (SIX:LONN) focused on commercializing its clinical-stage bioconjugation platform technology for the development of antibody-drug conjugates (ADCs) with best-in-class ...
Telesis Bio, Inc. (NASDAQ:TBIO – Get Free Report)’s stock price traded down 2.7% during mid-day trading on Tuesday . The stock traded as low as $0.70 and last traded at $0.73. 2,026 shares traded ...
Some sequences in the genome cause genes to be switched on or off. Until now, each of these gene switches, or so-called ...
Researchers from Durham University, Jagiellonian University (Poland) and the John Innes Center have achieved a breakthrough ...